We link multiple biomedical disciplines for research, training, and program development in the field of innate immunity.


The CIIID is focused on fostering basic science and clinical research, translational research and development, and training activities of the University of Washington and Seattle research community in the disciplines of innate immunity and immune disease. 

Upcoming Events

CIIID Quarterly Seminar (Fall)

Presenter:  Sam Miller, M.D., Professor of Medicine, Microbiology, Immunology, and Genome Sciences, University of Washington

Title:   "Studying human diversity in innate immunity using cellular GWAS"

CIIID Quarterly Seminar (Winter)

Presenter: Steve Polyak, Ph.D., Research Professor, Department of Global Health, University ofWashington Affiliate Investigator, Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center

Title: "Deciphering how drugs from nature suppress cellular inflammatory status"


On July 18-19, 2016, the Center for Innate Immunity and Immune Disease (CIIID) at the University of Washington hosted an Inaugural Symposium on Innate Immunity in Health and Disease.

To watch the recorded videos, click here


UW researchers make landmark discovery in fight against Zika virus, KOMO-TV, Sept. 12, 2016
Paving the way for potential treatments for Zika virus infections, UW Medicine researchers reported the first case of Zika-caused brain damage in the fetus of a nonhuman primate. Kristina Adams Waldorf, UW professor of obstetrics and gynecology, is the lead author of the study published in Nature Medicine.
Also in Seattle Times. HSNewsBeat.


Kristina M. Adams Waldorf, M.D.

Professor, Obstetrics & Gynecology, University of Washington

Dr. Adams Waldorf's laboratory is interested in understanding: 1) virulence and host factors that contribute to bacterial and viral trafficking into the amniotic cavity and fetus, 2) how activation of innate immune responses by pathogens within the placenta and amniotic fluid contributes to pregnancy complications and fetal injury, 3) how disruption of maternal-fetal tolerance by pathogens contributes to preterm birth, and 4) the role of novel therapeutics to prevent preterm birth and fetal injury due to pathogens.  Within this context, our work has been mainly focused on preterm birth and fetal injury related to Group B Streptococcus and more recently, the Zika virus.